PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $40,115,000 | +62.4% | 1,172,943 | -15.9% | 0.84% | +74.5% |
| Q3 2021 | $24,702,000 | -59.6% | 1,394,000 | +2.3% | 0.48% | -55.6% |
| Q2 2021 | $61,162,000 | +87.6% | 1,362,790 | +8.3% | 1.09% | +58.5% |
| Q1 2021 | $32,603,000 | +17.2% | 1,258,790 | -8.8% | 0.68% | +24.5% |
| Q4 2020 | $27,820,000 | +20.6% | 1,379,971 | +16.9% | 0.55% | -2.1% |
| Q3 2020 | $23,068,000 | +28.9% | 1,179,971 | +16.4% | 0.56% | +7.9% |
| Q2 2020 | $17,898,000 | +282.4% | 1,013,495 | +350.4% | 0.52% | +183.2% |
| Q4 2017 | $4,680,000 | – | 225,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
| BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
| COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
| Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
| Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
| Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
| EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
| JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
| Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |